Search

Your search keyword '"Bauer, Sebastian"' showing total 134 results

Search Constraints

Start Over You searched for: Author "Bauer, Sebastian" Remove constraint Author: "Bauer, Sebastian" Publisher elsevier bv Remove constraint Publisher: elsevier bv
134 results on '"Bauer, Sebastian"'

Search Results

4. Patient-Reported Outcomes and Tolerability in Patients Receiving Ripretinib versus Sunitinib After Treatment with Imatinib in INTRIGUE, a Phase 3, Open-Label Study

8. A post hoc analysis of the EPAZ trial: The role of geriatric variables in elderly soft tissue sarcoma patients on toxicity and outcome

9. Circulating tumor DNA analysis of the phase III VOYAGER trial: KIT mutational landscape and outcomes in patients with advanced gastrointestinal stromal tumor treated with avapritinib or regorafenib

10. Controversies in the management of patients with soft tissue sarcoma: Recommendations of the Conference on State of Science in Sarcoma 2022

13. Best clinical management of tenosynovial giant cell tumour (TGCT): A consensus paper from the community of experts

14. Is preoperative CT-guided biopsy a valuable tool in the diagnostic workup of patients with visceral and retroperitoneal sarcoma?

15. Gene expression-based prediction of pazopanib efficacy in sarcoma

19. Transcutaneous auricular vagus nerve stimulation influences gastric motility: A randomized, double-blind trial in healthy individuals

23. Postoperative outcomes and surgical ratio at a newly established epilepsy center: The first 100 procedures

24. Avapritinib in unresectable or metastatic PDGFRA D842V-mutant gastrointestinal stromal tumours: Long-term efficacy and safety data from the NAVIGATOR phase I trial

26. Advantages of methohexital over amobarbital in determining hemispheric language and memory lateralization in the Wada test – A retrospective study

27. A modular cement-based subsurface heat storage: Performance test, model development and thermal impacts

28. SARS-CoV-2-related rapid reorganization of an epilepsy outpatient clinic from personal appointments to telemedicine services: A German single-center experience

29. Genome-wide microRNA profiling of plasma from three different animal models identifies biomarkers of temporal lobe epilepsy

31. Avapritinib in advanced PDGFRA D842V-mutant gastrointestinal stromal tumour (NAVIGATOR): a multicentre, open-label, phase 1 trial

32. Ripretinib in patients with advanced gastrointestinal stromal tumours (INVICTUS): a double-blind, randomised, placebo-controlled, phase 3 trial

33. Could the 2017 ILAE and the four-dimensional epilepsy classifications be merged to a new “Integrated Epilepsy Classification”?

34. Predicting outcome of epilepsy surgery in clinical practice: Prediction models vs. clinical acumen

35. Randomised phase II trial of trofosfamide vs. doxorubicin in elderly patients with untreated metastatic soft-tissue sarcoma

37. Argonaute-2 sequencing of rodent status epilepticus models identifies multiple microRNA targets for seizure suppression

39. Electrical stimulation of the ventral hippocampal commissure delays experimental epilepsy and is associated with altered microRNA expression

40. Pexidartinib versus placebo for advanced tenosynovial giant cell tumour (ENLIVEN): a randomised phase 3 trial

43. Invasive EEG-electrodes in presurgical evaluation of epilepsies: Systematic analysis of implantation-, video-EEG-monitoring- and explantation-related complications, and review of literature

45. Dual-center, dual-platform microRNA profiling identifies potential plasma biomarkers of adult temporal lobe epilepsy

46. Trends in resource utilization and prescription of anticonvulsants for patients with active epilepsy in Germany from 2003 to 2013 — A ten-year overview

47. The tyrosine kinase inhibitor crizotinib does not have clinically meaningful activity in heavily pre-treated patients with advanced alveolar rhabdomyosarcoma with FOXO rearrangement: European Organisation for Research and Treatment of Cancer phase 2 trial 90101 ‘CREATE’

50. Crizotinib achieves long-lasting disease control in advanced papillary renal-cell carcinoma type 1 patients with MET mutations or amplification. EORTC 90101 CREATE trial

Catalog

Books, media, physical & digital resources